Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 160, 108027
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver diseaseJournal of Gastroenterology, 2013
- Diagnosis of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJournal of Pediatric Gastroenterology and Nutrition, 2012
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitisHepatology, 2010
- Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndromeProceedings of the Nutrition Society, 2010
- Nonalcoholic Fatty Liver Disease: Pathology and PathogenesisAnnual Review of Pathology: Mechanisms of Disease, 2010
- Heritability of Nonalcoholic Fatty Liver DiseaseGastroenterology, 2009
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)Progress in Lipid Research, 2009
- Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summaryJournal of Gastroenterology and Hepatology, 2007
- Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).Journal of Clinical Investigation, 1997
- Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in BloodNature, 1969